APCI1307K Mutations and Forkhead Box Gene (FOXO1A): Another Piece of an Interesting Correlation

Abstract

Purpose

Germline nonsense and frameshift mutations in the adenomatous polyposis coli (APC) gene are found in approximately 90% of individuals affected by familial adenomatous polyposis (FAP) and a genotype-phenotype relationship has been observed. Missense mutations have also been found in a few cases, even if their role in FAP is still unknown. An association between a missense mutation, APC I1307K, and the risk of sporadic colorectal cancer (CRC) has been reported. In order to improve the knowledge about the genetic effect of APC I1307K on the phenotype, we tried a new approach using matrix-assisted laser desorption/ionization mass spectrometry (MALDI/MS).

Experimental design

An APC mutation (I1307K) was found in an index case of a non-Jewish woman and her son with attenuated familial adenomatous polyposis (A-FAP) and no family history of cancer. In order to evaluate whether the presence and abundance of the ionic species are related to the presence of cancer or the presence of mutation, comparative analyses of 11 healthy clean-colon subjects, 59 patients with CRC (stage II n=19, stage III n=23, stage IV n=17) without polyps, and 9 FAP patients, carriers of a nonsense mutation in the APC gene, were evaluated.

Results

Comparative analysis of serum protein profiles of the index patient and her healthy son, FAP and sporadic CRC patients, and subjects with preneoplastic lesions showed a characteristic abundance of ionic species at m/z 905, which was not present in healthy controls. Two peptides were identified from MALDI/MS/MS spectra of m/z 905 belonging to the kininogen-1 precursor and the human forkhead box protein 01A (FOXO1A). FOXO1A was present in only two subjects carrying I1307K, but not in other patients.

Conclusions

Our findings seem to suggest a relationship between m/z 905, FOXO1A and the development and growth of colorectal cancer. FOXO1A fragment determination in serum with MALDI/MS might be a promising approach for early detection of colon carcinoma or for the development of targeted therapies.

Keywords

FOXO1A Colorectal cancer APC I1307K

References

Mitchell

R.J.

, Brewster

, Campbell

. Accuracy of reporting of family history of colorectal cancer. Gut 2004; 53: 291–5.

Beroud

, Soussi

. APC gene: database of germline and somatic mutations in human tumours and cell lines. Nucleic Acids Res 1996; 24: 121–4.

Kielman

M.F.

, Rindapaa

, Gaspar

. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 2002; 32: 594–605.

Laken

S.J.

, Petersen

G.M.

, Gruber

S.B.

. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997; 17: 79–83.

Gryfe

, Di Nicola

, Lal

, Gallinger

, Redston

. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 1999; 64: 378–84.

Strul

, Barenboim

, Leshno

. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. Cancer Epidemiol Biomarkers Prev 2003; 12: 1012–5.

Sieber

, Lipton

, Heinimann

, Tomlinson

. Colorectal tumourigenesis in carriers of the APC I1307K variant: lone gunman or conspiracy? J Pathol 2003; 199: 137–9.

Zauber

N.P.

, Sabbath-Solitare

, Marotta

S.P.

, Bishop

D.T.

. The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium. J Pathol 2003; 199: 146–51.

Seraglia

, Ragazzi

, Vogliardi

. Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 2005; 40: 123–6.

10.

Seraglia

, Molin

, Tonidandel

. An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis. J Mass Spectrom 2007; 42: 1606–12.

11.

Kaestner

K.H.

, Knochel

, Martinez

D.E.

. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000; 14: 142–6.

12.

Huang

, Regan

K.M.

, Lou

, Chen

, Tindall

D.J.

. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 2006; 314: 294–7.

13.

Hoogeboom

, Essers

M.A.

, Polderman

P.E.

, Voets

, Smits

L.M.

, Burgering

B.M.

. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J Biol Chem 2008; 283: 9224–30.

14.

Kim

J.H.

, Kim

M.K.

, Lee

H.E.

. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol 2007; 20: 835–42.

15.

Roy

U.K.

, Henkhaus

R.S.

, Ignatenko

N.A.

, Mora

, Fultz

K.E.

, Gerner

E.W.

. Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc. Mol Carcinog 2008; 47: 947–55.

16.

Yoshida

, Wang

I.C.

, Yoder

H.M.

, Davidson

N.O.

, Costa

R.H.

. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology 2007; 132: 1420–31.

17.

Calnan

D.R.

, Brunet

. The FoxO code. Oncogene 2008; 27: 2276–88.

18.

Liu

, Kao

T.P.

, Huang

. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 2008; 27: 4733–44.